273 related articles for article (PubMed ID: 30142881)
21. The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.
Di Maira G; Gentilini A; Pastore M; Caligiuri A; Piombanti B; Raggi C; Rovida E; Lewinska M; Andersen JB; Borgo C; Salvi M; Ottaviani D; Ruzzene M; Marra F
Oncogenesis; 2019 Oct; 8(11):61. PubMed ID: 31641101
[TBL] [Abstract][Full Text] [Related]
22. Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.
Zakharia K; Miyabe K; Wang Y; Wu D; Moser CD; Borad MJ; Roberts LR
Transl Oncol; 2019 Jan; 12(1):143-153. PubMed ID: 30316146
[TBL] [Abstract][Full Text] [Related]
23. Anti-adipogenic and Pro-lipolytic Effects on 3T3-L1 Preadipocytes by CX-4945, an Inhibitor of Casein Kinase 2.
Yadav AK; Jang BC
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806278
[TBL] [Abstract][Full Text] [Related]
24. Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines.
Hwang DW; So KS; Kim SC; Park KM; Lee YJ; Kim SW; Choi CM; Rho JK; Choi YJ; Lee JC
Pancreas; 2017 Apr; 46(4):575-581. PubMed ID: 28196025
[TBL] [Abstract][Full Text] [Related]
25. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
26. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
[TBL] [Abstract][Full Text] [Related]
27. 4,5,7-Trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects.
Birus R; El-Awaad E; Ballentin L; Alchab F; Aichele D; Ettouati L; Götz C; Le Borgne M; Jose J
FEBS Open Bio; 2022 Feb; 12(2):394-411. PubMed ID: 34873879
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
Quotti Tubi L; Gurrieri C; Brancalion A; Bonaldi L; Bertorelle R; Manni S; Pavan L; Lessi F; Zambello R; Trentin L; Adami F; Ruzzene M; Pinna LA; Semenzato G; Piazza F
J Hematol Oncol; 2013 Oct; 6():78. PubMed ID: 24283803
[TBL] [Abstract][Full Text] [Related]
29. CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(-) HNSCC Cell Lines.
Trembley JH; Li B; Kren BT; Gravely AA; Caicedo-Granados E; Klein MA; Ahmed K
Biomedicines; 2021 May; 9(5):. PubMed ID: 34070147
[TBL] [Abstract][Full Text] [Related]
30. TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.
Lustri AM; Di Matteo S; Fraveto A; Costantini D; Cantafora A; Napoletano C; Bragazzi MC; Giuliante F; De Rose AM; Berloco PB; Grazi GL; Carpino G; Alvaro D
PLoS One; 2017; 12(9):e0183932. PubMed ID: 28873435
[TBL] [Abstract][Full Text] [Related]
31. MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
Bian Y; Han J; Kannabiran V; Mohan S; Cheng H; Friedman J; Zhang L; VanWaes C; Chen Z
Int J Biol Sci; 2015; 11(4):411-22. PubMed ID: 25798061
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia.
Klink M; Rahman MA; Song C; Dhanyamraju PK; Ehudin M; Ding Y; Steffens S; Bhadauria P; Iyer S; Aliaga C; Desai D; Huang S; Claxton D; Sharma A; Gowda C
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33807974
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells.
Zaman MS; Johnson AJ; Petersingham G; Muench GW; Dong Q; Wu MJ
Biometals; 2019 Dec; 32(6):861-873. PubMed ID: 31583500
[TBL] [Abstract][Full Text] [Related]
34. Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945.
Rosales M; Rodríguez-Ulloa A; Besada V; Ramón AC; Pérez GV; Ramos Y; Guirola O; González LJ; Zettl K; Wiśniewski JR; Perera Y; Perea SE
Cells; 2021 Feb; 10(2):. PubMed ID: 33562780
[TBL] [Abstract][Full Text] [Related]
35. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Kim J; Hwan Kim S
PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
[TBL] [Abstract][Full Text] [Related]
36. Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma.
Schwarz R; Richter A; Ito ERD; Murua Escobar H; Junghanß C; Hinz B
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458589
[TBL] [Abstract][Full Text] [Related]
37. CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity.
Masłyk M; Janeczko M; Martyna A; Kubiński K
Mol Cell Biochem; 2017 Nov; 435(1-2):193-196. PubMed ID: 28501934
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate Reductase Results in Synergistic Effect on Acute Lymphoblastic Leukemia Cells.
Wińska P; Widło Ł; Skierka K; Krzyśko A; Koronkiewicz M; Cieśla JM; Cieśla J; Bretner M
Anticancer Res; 2019 Jul; 39(7):3531-3542. PubMed ID: 31262877
[TBL] [Abstract][Full Text] [Related]
39. Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance.
D'Amore C; Borgo C; Sarno S; Salvi M
Cell Oncol (Dordr); 2020 Dec; 43(6):1003-1016. PubMed ID: 33052585
[TBL] [Abstract][Full Text] [Related]
40. Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
Agarwal M; Nitta RT; Li G
J Mol Genet Med; 2013 Dec; 8(1):. PubMed ID: 25264454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
